Lamivudine Patent Expiration
Lamivudine is Used for treating hepatitis B infection. It was first introduced by Viiv Healthcare Co
Lamivudine Patents
Given below is the list of patents protecting Lamivudine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Epivir |
US6004968 (Pediatric) | Pharmaceutical compositions containing lamivudine |
Sep 20, 2018
(Expired) | Viiv Hlthcare |
| Epivir-hbv |
US6004968 (Pediatric) | Pharmaceutical compositions containing lamivudine |
Sep 20, 2018
(Expired) | Glaxosmithkline |
| Epivir | US6004968 | Pharmaceutical compositions containing lamivudine |
Mar 20, 2018
(Expired) | Viiv Hlthcare |
| Epivir-hbv | US6004968 | Pharmaceutical compositions containing lamivudine |
Mar 20, 2018
(Expired) | Glaxosmithkline |
| Epivir |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Viiv Hlthcare |
| Epivir-hbv |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Glaxosmithkline |
| Epivir | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
| Epivir | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
| Epivir-hbv | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Glaxosmithkline |
| Epivir-hbv |
USRE39155 (Pediatric) | Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
Jan 02, 2014
(Expired) | Glaxosmithkline |
| Epivir-hbv | USRE39155 | Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
Jul 02, 2013
(Expired) | Glaxosmithkline |
Lamivudine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List